Rebopag 25mg Tablet

PRODUCT INTRODUCTION

Rebopag 25mg Tablet is a pharmaceutical product designed to address specific medical conditions. It belongs to a class of medications known as thrombopoietin receptor agonists. These drugs work by stimulating the production of platelets in the body. Rebopag 25mg Tablet is formulated to provide a controlled and effective way to manage thrombocytopenia, a condition characterized by a low platelet count in the blood. It comes in tablet form for convenient oral administration.

USES OF Rebopag 25mg Tablet

Rebopag 25mg Tablet is primarily prescribed for patients suffering from thrombocytopenia associated with chronic liver disease (CLD), including chronic hepatitis C infection. It is also indicated for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an inadequate response to other therapies. Additionally, it may be used in certain cases of thrombocytopenia in patients with aplastic anemia.

BENEFITS OF Rebopag 25mg Tablet

• Stimulates platelet production: Rebopag 25mg Tablet effectively stimulates the production of platelets in the bone marrow, thereby increasing the platelet count in the blood.
• Reduces bleeding risk: By elevating platelet levels, Rebopag helps reduce the risk of bleeding episodes associated with thrombocytopenia, improving overall patient safety and quality of life.
• Management of chronic conditions: Rebopag 25mg Tablet offers a long-term solution for managing thrombocytopenia associated with chronic liver disease and chronic immune thrombocytopenic purpura, providing patients with a reliable treatment option to control their condition.

SIDE EFFECTS OF Rebopag 25mg Tablet

While Rebopag 25mg Tablet offers significant therapeutic benefits, it may also be associated with certain side effects. Common side effects include:

• Headache
• Nausea
• Diarrhea
• Fatigue
• Muscle pain
• Dizziness
• Elevated liver enzymes

It’s important for patients to discuss any potential side effects with their healthcare provider, as well as report any unusual symptoms experienced during the course of treatment.